Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Buy
9,952
+188
+2% +$64.4K 0.44% 63
2026
Q1
$3.44M Buy
9,764
+224
+2% +$79.9K 0.48% 57
2025
Q4
$3.12M Sell
9,540
-14
-0.1% -$4.44K 0.45% 56
2025
Q3
$2.7M Buy
9,554
+324
+4% +$94K 0.41% 72
2025
Q2
$2.58M Buy
9,230
+229
+3% +$64.9K 0.42% 65
2025
Q1
$2.8M Buy
9,001
+49
+0.5% +$14.5K 0.5% 57
2024
Q4
$2.33M Buy
8,952
+4
+0% +$1.19K 0.42% 70
2024
Q3
$2.88M Sell
8,948
-67
-0.7% -$21.9K 0.52% 54
2024
Q2
$2.82M Sell
9,015
-289
-3% -$84.9K 0.54% 47
2024
Q1
$2.65M Sell
9,304
-181
-2% -$53K 0.53% 54
2023
Q4
$2.73M Sell
9,485
-778
-8% -$212K 0.6% 47
2023
Q3
$2.76M Sell
10,263
-312
-3% -$77.9K 0.67% 44
2023
Q2
$2.35M Sell
10,575
-418
-4% -$97K 0.57% 50
2023
Q1
$2.66M Buy
10,993
+10,883
+9,894% +$2.67M 0.68% 44
2022
Q4
$28.8K Hold
110
0.01% 217
2022
Q3
$25K Buy
110
+49
+80% +$11.9K 0.01% 207
2022
Q2
$15K Hold
61
﹤0.01% 265
2022
Q1
$15K Hold
61
﹤0.01% 258
2021
Q4
$14K Hold
61
﹤0.01% 263
2021
Q3
$13K Hold
61
﹤0.01% 260
2021
Q2
$15K Sell
61
-30
-33% -$7.38K ﹤0.01% 249
2021
Q1
$23K Buy
91
+51
+128% +$12.2K 0.01% 237
2020
Q4
$9K Sell
40
-16
-29% -$3.69K ﹤0.01% 279
2020
Q3
$7.63M Sell
56
-1
-2% -$248 2.69% 8
2020
Q2
$13K Buy
57
+30
+111% +$6.84K 0.01% 291
2020
Q1
$5K Sell
27
-2
-7% -$437 ﹤0.01% 281
2019
Q4
$7 Buy
+29
New +$6.39K ﹤0.01% 278

Other funds holding AMGN

Leelyn Smith's AMGN Position: Q2 2026 in Review

Leelyn Smith increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $64.4K and bringing the position to 9,952 shares worth $3.6M. The position accounts for 0.44% of the portfolio, ranked #63.

Leelyn Smith first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.63M in Q3 2020. 1,322 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Leelyn Smith held 9,952 shares of Amgen worth $3.6M as of Q2 2026.
  • Leelyn Smith bought 188 Amgen shares in Q2 2026, an estimated $64.4K.
  • Amgen made up 0.44% of Leelyn Smith's portfolio in Q2 2026, its #63 holding.
  • Leelyn Smith first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Leelyn Smith's Amgen position peaked at $7.63M in Q3 2020.
  • 1,322 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.